Further studies have demonstrated the clinical significance of Tks5 in a number of different cancer types, including breast cancer, gliomas, and lung adenocarcinoma, as well as colon and prostate cancer [37,38,39,40]. The gene discussed is SH3PXD2A; the disease is cancer.